Globus Medical, Inc.

Globus Medical, Inc.

GMEDยทNYSE

$77.95

-0.38%
HealthcareMedical - Devices

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

At a Glance

Live Snapshot
Market Cap$10.51B
EPS3.9800
P/E Ratio19.59
Earnings Date07/30/2026
3Y+187.0%
5Y+272.0%
10Y+421.0%
3Y+183.0%
5Y+426.0%
10Y+416.0%
3Y+322.0%
5Y+279.0%
10Y+338.0%
Globus Medical, Inc.

Globus Medical, Inc. Profit Bridge

GMED ยท NYSE
Revenue2.94B
Cost of Goods Sold (957.80M)
Gross Profit1.98B
Operating Expenses (1.50B)
Operating Income479.80M
Interest Expense (0.00)
Other Income/Expense130.10M
Pretax Income609.90M
Income Tax (72.00M)
Net Income537.90M
Net Income
537.90M

Profitability Analysis

Gross Margin

67.4%

Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.

Operating Margin

16.3%

Healthy operating margins demonstrate effective cost control and strong business fundamentals.

Net Profit Margin

18.3%

Strong net margins indicate efficient operations and favorable tax/interest management.

Effective Tax Rate

11.8%

Below-average tax rate suggests effective tax planning, favorable jurisdictions, or tax credits.

Profitability Insight

High margin compression: Large gap between gross and net margins suggests operational inefficiencies or heavy debt burden. Focus on expense management and deleveraging.

Globus Medical, Inc. Income Statement

GMED โ€ข NYSE

Globus Medical, Inc. Income StatementDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
REVENUE
2.9B
2.5B
1.6B
1B
958.1M
789M
785.4M
713M
636M
564M
544.8M
474.4M
434.5M
386M
331.5M
288.2M
254.3M
GROSS PROFIT
(957.8M)
(1B)
(548.2M)
(263.7M)
(239.2M)
(217.5M)
(180M)
(159.4M)
(150.5M)
(134.7M)
(132.3M)
(110.8M)
(100.3M)
(75.2M)
(68.8M)
(53.8M)
(41.6M)
2B
1.5B
1B
759.1M
718.9M
571.6M
605.4M
553.6M
485.5M
429.3M
412.4M
363.6M
334.1M
310.8M
262.7M
234.4M
212.7M
OPERATING INCOME
(1.5B)
(1.3B)
(887.2M)
(531.2M)
(546.9M)
(460.1M)
(433.4M)
(384.2M)
(323.7M)
(275.1M)
(240.2M)
(225.2M)
(232.4M)
(196M)
(165.3M)
(146.7M)
(130.8M)
(1.3B)
(981M)
(643.4M)
(432.1M)
(408.1M)
(354.8M)
(354.8M)
(311.6M)
(267.8M)
(222.2M)
(214M)
(187.8M)
(182.5M)
(168.9M)
(140.4M)
(122.6M)
(108.4M)
(185M)
(163.8M)
(124M)
(73M)
(97.3M)
(84.5M)
(60.1M)
(55.5M)
(43.7M)
(44.5M)
(36.3M)
(31.2M)
(26.9M)
(27.9M)
(23.5M)
(21.3M)
(20.5M)
479.8M
166M
133.1M
228M
172M
111.4M
172M
169.3M
161.8M
154.1M
172.2M
138.4M
101.7M
114.8M
97.4M
87.7M
81.9M
PRE-TAX INCOME
(0.0)
(4.2M)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
7.1M
-4.2M
20.1M
14.2M
9.3M
14M
17.4M
13.3M
6.6M
3.1M
1.3M
805K
467K
80K
0.0
0.0
0.0
(0.0)
(173.1M)
(119.7M)
(26M)
(41.4M)
(20.9M)
(18.6M)
(17.1M)
(12.2M)
(8.5M)
-6.4M
(5.4M)
(23.1M)
-786K
(1.5M)
(2.8M)
(1.9M)
130.1M
-45.3M
32.3M
15.1M
8.5M
14.5M
18M
19.3M
8.1M
3.1M
583K
280K
328K
-140K
-1.9M
-2.7M
-2M
609.9M
120.7M
165.4M
243M
180.4M
125.9M
189.9M
188.6M
169.9M
157.3M
172.8M
138.6M
102M
114.7M
96.9M
87.7M
81.8M
NET INCOME
(72M)
(17.7M)
(42.5M)
(52.9M)
(31.2M)
(23.6M)
(34.7M)
(32.1M)
(62.6M)
(52.9M)
(60M)
(46.2M)
(33.4M)
(40.8M)
(36.2M)
(33.3M)
(29.7M)
537.9M
103M
122.9M
190.2M
149.2M
102.3M
155.2M
156.5M
107.3M
104.3M
112.8M
92.5M
68.6M
73.8M
60.8M
54.5M
48.7M

SEC Filings

GMED - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
10-Q

10-Q 2026 Q1

Q1

May 07, 2026
March 31, 2026
2026
8-K

8-K 2026

N/A

May 07, 2026
May 07, 2026
2026
DEF 14A

DEF 14A 2026

N/A

April 24, 2026
June 03, 2026
2026
8-K

8-K 2026

N/A

March 23, 2026
March 23, 2026
2026
8-K

8-K 2026

N/A

February 24, 2026
February 24, 2026
2026
10-K

10-K 2025 FY

FY

February 24, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

January 07, 2026
January 07, 2026
2026
10-Q

10-Q 2025 Q3

Q3

November 06, 2025
September 30, 2025
2025
8-K

8-K 2025

N/A

November 06, 2025
November 06, 2025
2025
10-Q

10-Q 2025 Q2

Q2

August 07, 2025
June 30, 2025
2025
Showing 1 to 10 of 210 filings